BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22027622)

  • 21. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.
    Goodnough LT; Rudnick S; Price TH; Ballas SK; Collins ML; Crowley JP; Kosmin M; Kruskall MS; Lenes BA; Menitove JE
    N Engl J Med; 1989 Oct; 321(17):1163-8. PubMed ID: 2677725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
    Schreiber S; Howaldt S; Schnoor M; Nikolaus S; Bauditz J; Gasché C; Lochs H; Raedler A
    N Engl J Med; 1996 Mar; 334(10):619-23. PubMed ID: 8592524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoiesis after therapy with recombinant human erythropoietin: a dose-response study in anemic cancer surgery patients.
    Braga M; Gianotti L; Gentilini O; Vignali A; Corizia L; Di Carlo V
    Vox Sang; 1999; 76(1):38-42. PubMed ID: 9933852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
    Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
    Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human erythropoietin administration in cardiac surgery.
    Yazicioğlu L; Eryilmaz S; Sirlak M; Inan MB; Aral A; Taşöz R; Eren NT; Kaya B; Akalin H
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):741-5. PubMed ID: 11581607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery.
    Madi-Jebara SN; Sleilaty GS; Achouh PE; Yazigi AG; Haddad FA; Hayek GM; Antakly MC; Jebara VA
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):59-63. PubMed ID: 14973801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
    Fischl M; Galpin JE; Levine JD; Groopman JE; Henry DH; Kennedy P; Miles S; Robbins W; Starrett B; Zalusky R
    N Engl J Med; 1990 May; 322(21):1488-93. PubMed ID: 2186273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
    Biggs JC; Atkinson KA; Booker V; Concannon A; Dart GW; Dodds A; Downs K; Szer J; Turner J; Worthington R
    Bone Marrow Transplant; 1995 Jan; 15(1):129-34. PubMed ID: 7742745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C; Blumberg A
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied.
    Alvarez JC; Santiveri FX; Ramos I; Vela E; Puig L; Escolano F
    Transfusion; 2008 Mar; 48(3):519-25. PubMed ID: 18067499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery.
    García-Erce JA; Cuenca J; Martínez F; Cardona R; Pérez-Serrano L; Muñoz M
    Transfus Med; 2006 Oct; 16(5):335-41. PubMed ID: 16999756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P; Andre JL; Treize G; Leroy B
    Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: an unblinded randomized pilot clinical trial.
    Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Chan CT; Wong PY; Crowther MA; Hozhabri S; Beattie WS
    Anesthesiology; 2012 Mar; 116(3):613-21. PubMed ID: 22354243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery.
    Cuenca J; García-Erce JA; Martínez F; Pérez-Serrano L; Herrera A; Muñoz M
    Transfusion; 2006 Jul; 46(7):1112-9. PubMed ID: 16836557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
    Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
    Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
    Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].
    Georgopoulos D; Matamis D; Routsi C; Michalopoulos A; Maggina N; Dimopoulos G; Zakynthinos E; Nakos G; Thomopoulos G; Mandragos K; Maniatis A;
    Crit Care; 2005 Oct; 9(5):R508-15. PubMed ID: 16277712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.